Medicare Enrolled

Dr. Wassim El-Harake, M.D.

Endocrinology · Joliet, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3033 W JEFFERSON ST STE 206, Joliet, IL 60435
8157303304
In practice since 2005 (20 years)
NPI: 1346236098 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. El-Harake from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. El-Harake? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. El-Harake

Dr. Wassim El-Harake is an endocrinology specialist in Joliet, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. El-Harake performed 4,871 Medicare services across 663 unique beneficiaries.

Between the years covered by Open Payments, Dr. El-Harake received a total of $17,901 from 51 pharmaceutical and/or device companies across 951 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. El-Harake is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 11% volume in IL $17,901 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,871
Medicare services
Top 11% in IL for endocrinology
663
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~244 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
2,891 $42 $85
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
1,376 $66 $150
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
173 $82 $120
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
159 $66 $100
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
121 $109 $175
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
106 $10 $40
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
16 $121 $206
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
16 $29 $30
Quadrivalent influenza vaccine, cell-culture derived
A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics.
13 $33 $40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$17,901
Total received (2018-2024)
Avg $2,557/year across 7 years
Top 15% in IL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
951
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,901 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,175
2023
$1,533
2022
$2,559
2021
$2,834
2020
$2,312
2019
$3,867
2018
$3,622

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$237
Insulet Corporation
$229
ABBVIE INC.
$167
Abbott Laboratories
$144
Xeris Pharmaceuticals, Inc.
$141
Novo Nordisk Inc
$48
RECORDATI_RARE_DISEASES_INC.
$46
Amneal Pharmaceuticals LLC
$35
Amgen Inc.
$31
Corcept Therapeutics
$31
AstraZeneca Pharmaceuticals LP
$20
CeQur Corporation
$15
Exact Sciences Corporation
$15
Bayer Healthcare Pharmaceuticals Inc.
$15
Top 3 companies account for 54.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,123
SANOFI-AVENTIS U.S. LLC
$1,494
AstraZeneca Pharmaceuticals LP
$1,406
Lilly USA, LLC
$1,190
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,072
Amgen Inc.
$1,028
Abbott Laboratories
$979
Corcept Therapeutics
$863
ABBVIE INC.
$736
Becton, Dickinson and Company
$644
Merck Sharp & Dohme Corporation
$627
Insulet Corporation
$518
Antares Pharma, Inc.
$473
Allergan, Inc.
$404
Shire North American Group Inc
$366
Dexcom, Inc.
$347
Janssen Pharmaceuticals, Inc
$343
Bayer HealthCare Pharmaceuticals Inc.
$339
AbbVie Inc.
$312
Medtronic, Inc.
$243
Tandem Diabetes Care, Inc.
$220
MannKind Corporation
$218
Intuity Medical Inc
$213
RECORDATI_RARE_DISEASES_INC.
$202
Xeris Pharmaceuticals, Inc.
$159
Ascendis Pharma Inc
$152
PFIZER INC.
$151
Merck Sharp & Dohme LLC
$133
AbbVie, Inc.
$117
CeQur Corporation
$102
Medtronic MiniMed, Inc.
$88
Bayer Healthcare Pharmaceuticals Inc.
$62
Mannkind Corporation
$59
Amneal Pharmaceuticals LLC
$55
Allergan Inc.
$52
Supernus Pharmaceuticals, Inc.
$51
Watermark Medical, Inc.
$44
Novartis Pharmaceuticals Corporation
$41
DEXCOM, INC.
$38
Nestle HealthCare Nutrition Inc.
$35
Horizon Therapeutics plc
$32
Clarus Therapeutics Inc.
$26
Biohaven Pharmaceuticals, Inc.
$22
Lundbeck LLC
$20
Embecta Corp.
$18
EUSA Pharma (US) LLC
$17
Exact Sciences Corporation
$15
Ultragenyx Pharmaceutical Inc.
$15
Currax Pharmaceuticals LLC
$14
Radius Health, Inc.
$13
Echosens North America, Inc.
$12
Top 3 companies account for 28.1% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIMOVIG · AIRSUPRA · ARES HOME SLEEP TESTING DEVICE · Aimovig · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BELSOMRA · BYSTOLIC · CHANTIX · CONTRAVE · CREON · CeQur Simplicity · Cologuard Collection Kit · Corlanor · Crysvita · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · ELIQUIS · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FibroScan · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · INVOKAMET · INVOKANA · ISTURISA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LINZESS · LYUMJEV · Levemir · MINIMED 770G · MOUNJARO · Minimed 530G · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NOCDURNA · NURTEC ODT · NovoLog · OTREXUP · Omnipod · Otezla · Otrexup · Ozempic · Pogo Automatic Blood Glucose Monitoring System · Prolia · QTERN · QULIPTA · RECORLEV · REXULTI · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SKYTROFA · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STEGLUJAN · SYMBICORT · SYNTHROID · Saxenda · Sylvant · Synthroid · TEPEZZA · TLANDO · TOUJEO · TRADJENTA · TRULICITY · Tymlos · UBRELVY · UNITHROID · VIAGRA · VIBERZI · VRAYLAR · Victoza · Wegovy · XARELTO · XYOSTED · ZENPEP · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Joliet?
Compare endocrinologists in the Joliet area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
55
Per 100K population
7.9
County median income
$107,799
Nearest hospital
SAINT JOSEPH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. El-Harake is a mixed practice specialist, with above-average Medicare volume (top 11% in IL), with low-engagement industry engagement in the top 15% of IL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. El-Harake experienced with hospital follow-up visit, low complexity?
Based on Medicare claims data, Dr. El-Harake performed 2,891 hospital follow-up visit, low complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. El-Harake receive payments from pharmaceutical companies?
Yes. Dr. El-Harake received a total of $17,901 from 51 companies across 951 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. El-Harake's costs compare to other endocrinologists in Joliet?
Dr. El-Harake's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. El-Harake) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →